Case Based Roundtable Logo

This roundtable series discusses the option of testing circulating tumor DNA molecular residual disease for personalized care in patients with lung cancer, as discussed by key opinion leaders at virtual live events and interviews.

Using ctDNA Molecular Residual Disease Testing in Lung Cancer

New content coming soon